Asthma prevalence has been on the increase, especially in North America compared with other continents. However, the prevalence of asthma differs worldwide, and in many countries the prevalence is stable or decreasing. This highlights the influence of environmental exposures, such as allergens, air pollution, and the environmental microbiome, on disease etiology and pathogenesis. The epigenome might provide the unifying mechanism that translates the influence of environmental exposures to changes in gene expression, respiratory epithelial function, and immune cell skewing that are hallmarks of asthma. In this review we will introduce the concept of the environmental epigenome in asthmatic patients, summarize previous publications of relevance to this field, and discuss future directions.
Interasma on Twitter
Interasma Top story: European Academy of Allergy and Clinical Immunology calls for improved food allergy labelling to protect… https://t.co/BoO5npfZel
Interasma RT @Aller_MD: My Tweeted Times https://t.co/36WLWcQjoy - top stories by @DrLindaMD, @GavinPrestonMD
Interasma Interasma https://t.co/benOb7sQz7 - top stories by @alfredogweb, @LYNURRUTIA, @sergiobarbaecua
Interasma RT @Aller_MD: Top story: Percentage of young U.S. children who don’t receive any vaccines has quadrupled since 2001 - The Washington Post h…